Generics - Ranbaxy Laboratories, Financial

Filter

Popular Filters

Ranbaxy rises on 4th-qtr performance, but can this continue?

Ranbaxy rises on 4th-qtr performance, but can this continue?

05-02-2014

Ranbaxy Laboratories, India’s largest generic drugmaker by sales, saw its shares rise 5.6% to 340 rupees…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Ranbaxy 2nd-qtr sales fall 18%; reports loss

08-08-2013

India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) reported second-quarter 2013 financial results,…

FinancialGenericsRanbaxy Laboratories

EU Commission fines Lundbeck and other Pharmas over "pay-for-delay" deals

19-06-2013

In a much awaited decision following its investigations of patent settlements (or pay-for-delay deals)…

ActaviscitalopramEuropeFinancialGenericsLegalLundbeckMerck KGaAMylan LaboratoriesNeurologicalPatentsPharmaceuticalRanbaxy Laboratories

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements

14-05-2013

In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Ranbaxy 1st-qtr 2013 earnings plunge 90% as sales fall 34%

08-05-2013

India's largest pharma company Ranbaxy Laboratories (BSE: 500359), which is majority owned by Japan's…

FinancialGenericsRanbaxy Laboratories

India's Ranbaxy posts 23% sales growth for 2012

26-02-2013

India's largest drugmaker Ranbaxy Laboratories (AB: BO) yesterday reported financial results for 2012,…

FinancialGenericsRanbaxy Laboratories

Ranbaxy Labs beats estimates, as 3rd-qtr sales leap 31%

09-11-2012

India's largest drugmaker Ranbaxy Laboratories (AB: BO) has reported financial results for the quarter…

FinancialGenericsRanbaxy Laboratories

Ranbaxy sales rocket 55%, net rises four-fold

11-05-2012

Ranbaxy Laboratories (AB: BO), India's largest drugmaker, came in with a stompingly good set of financial…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Ranbaxy posts $586 million loss due to charges

23-02-2012

India’s largest drugmaker Ranbaxy Laboratories (RAB: BO), which is 64% owned by Japan’s Daiichi…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Ranbaxy signs consent decree with US FDA over production practices

22-12-2011

India’s largest drugmaker Ranbaxy Laboratories (RANB: BO), which is 64% owned by Japan’s Daiichi…

Daiichi SankyoFinancialGenericsLegalNorth AmericaPharmaceuticalRanbaxy LaboratoriesRegulation

India’s Ranbaxy posts 3rd-qtr 2011 loss

10-11-2011

India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) posted its biggest quarterly loss in…

FinancialGenericsRanbaxy Laboratories

Back to top